IMVT
Immunovant, Inc. · Healthcare
Director Andrew J. Fromkin sold $491K of Immunovant, Inc.
Sold$490,697
$39.73Price
12,350Shares
−12%Stake
What IMVT did after the filing
- The stock from Wed, Dec 6 open, $39.65
- +1.0%
- S&P 500, same days
- +5.8%
Measured over 30 trading days, to the Jan 22 close.
Traded Fri, Dec 1. Filed Tue, Dec 5, 4:30 PM ET, after the close. Returns use the Dec 6 open and the Jan 22 close. Not investment advice.